Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- METIS Inaugurates 3rd-Phase Plan
December 17, 2007
- New Stock Exchange Market NEO to Stimulate Drug Discovery by Bioventures
December 17, 2007
- Medical Devices to Be Re-priced if They Are 1.7 Times More Expensive than Overseas
December 17, 2007
- BUSINESS NEWS IN BRIEF
December 17, 2007
- MEDICAL DEVICE NEWS IN BRIEF
December 17, 2007
- Re-Pricing Runs Counter to Innovation: Industry
December 17, 2007
- TOPICS／Number of Female MRs Increasing but Their Retention Rates Need Improvement
December 17, 2007
- Eisai Submits NDA for KES524 for Obesity
December 10, 2007
- Large Gap between Korosho and Council on Views on Kongo Shinryo
December 10, 2007
- Wyeth Submits 3rd NDA This Year
December 10, 2007
- Korosho to Set Up Group to Discuss Deregulations, Kongo Shinryo
December 10, 2007
- Astellas Aims at Becoming a Global Category Leader
December 10, 2007
- REGULATORY NEWS IN BRIEF
December 10, 2007
- Ban on Kongo Shinryo Should Be Lifted: Prof. Shimada
December 10, 2007
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
December 10, 2007
- Banyu Conducts PI Study in Japan and South Korea Ahead of US
December 10, 2007
- Revised Osteoporosis GL Discussed at JOS Meeting
December 10, 2007
- Geninax Posts \1.9 Bil. Sales in the 1st Month
December 10, 2007
- Clinical Trial Network Created by Six Universities
December 10, 2007
- Half of Physicians Start Osteoporosis Treatment in Patients with Reduced Bone Mass
December 10, 2007
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…